Molecular and Clinical Risk Factors for Recurrence of Skull Base Chordomas
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular and Clinical Risk Factors for Recurrence of Skull Base Chordomas
Authors
Keywords
-
Journal
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
Volume 72, Issue 9, Pages 816-823
Publisher
Oxford University Press (OUP)
Online
2013-08-21
DOI
10.1097/nen.0b013e3182a065d0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An integrated functional genomics approach identifies the regulatory network directed by brachyury (T ) in chordoma
- (2012) Andrew C Nelson et al. JOURNAL OF PATHOLOGY
- Fascin expression in skull base chordoma: correlation with tumor recurrence and dura erosion
- (2012) Ziyun Gao et al. MEDICAL ONCOLOGY
- Generation of chordoma cell line JHC7 and the identification of Brachyury as a novel molecular target
- (2011) Wesley Hsu et al. JOURNAL OF NEUROSURGERY
- Recurrent Chromosomal Copy Number Alterations in Sporadic Chordomas
- (2011) Long Phi Le et al. PLoS One
- The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells
- (2010) Romaine I. Fernando et al. JOURNAL OF CLINICAL INVESTIGATION
- Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study
- (2010) Nadège Presneau et al. JOURNAL OF PATHOLOGY
- Gain of chromosome 2p in chronic lymphocytic leukemia: significant heterogeneity and a new recurrent dicentric rearrangement
- (2010) Marie Jarosova et al. LEUKEMIA & LYMPHOMA
- Skull base chordomas: efficacy of surgery followed by carbon ion radiotherapy
- (2009) Satoshi Takahashi et al. ACTA NEUROCHIRURGICA
- Brachyury Expression in Extra-axial Skeletal and Soft Tissue Chordomas: A Marker that Distinguishes Chordoma From Mixed Tumor/Myoepithelioma/Parachordoma in Soft Tissue
- (2009) Roberto Tirabosco et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Response to imatinib plus sirolimus in advanced chordoma
- (2009) S. Stacchiotti et al. ANNALS OF ONCOLOGY
- Potential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathway
- (2009) N Presneau et al. BRITISH JOURNAL OF CANCER
- Target-driven exploratory study of imatinib mesylate in children with solid malignancies by the Innovative Therapies for Children with Cancer (ITCC) European Consortium
- (2009) Birgit Geoerger et al. EUROPEAN JOURNAL OF CANCER
- Impact of cytogenetic abnormalities on the management of skull base chordomas
- (2009) Kaith K. Almefty et al. JOURNAL OF NEUROSURGERY
- Gain of the short arm of chromosome 2 (2p) is a frequent recurring chromosome aberration in untreated chronic lymphocytic leukemia (CLL) at advanced stages
- (2009) Elise Chapiro et al. LEUKEMIA RESEARCH
- Analysis of the fibroblastic growth factor receptor-RAS/RAF/MEK/ERK-ETS2/brachyury signalling pathway in chordomas
- (2009) Asem AE Shalaby et al. MODERN PATHOLOGY
- T (brachyury) gene duplication confers major susceptibility to familial chordoma
- (2009) Xiaohong R Yang et al. NATURE GENETICS
- Brachyury, SOX-9 and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis
- (2008) Gerard J Oakley et al. MODERN PATHOLOGY
- Evaluation of 1p36 markers and clinical outcome in a skull base chordoma study
- (2007) Mauro Longoni et al. NEURO-ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started